Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy

Wenjing Bai

Jinxin Xu

Wenbin Gu

Danyang Wang

Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, School of Life Science and Technology, Xidian University & International Joint Research Center for Advanced Medical Imaging and Intelligent Diagnosis and Treatment, 266 Xinglong Section of Xifeng Road, Xi’an, Shaanxi 710126, P. R. China

Ying Cui

Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine

Weidong Rong

Xiaoan Du

Xiaoxia Li

Cuicui Xia

Qingqing Gan

Guantao He

Huahui Guo

Institute of Drug Discovery, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, China-New Zealand Joint Laboratory on Biomedicine and Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

Jinfeng Deng

Yuqiong Wu

Ray-Whay Chiu Yen

Srinivasan Yegnasubramanian

Department of Oncology, Johns Hopkins School of Medicine

Scott B. Rothbart

Cheng Luo

State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine

Linping Wu

Jinsong Liu

Stephen B. Baylin

Xiangqian Kong

Institute of Drug Discovery, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, China-New Zealand Joint Laboratory on Biomedicine and Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences